The CHA2DS2-VASc score is a clinical tool used to assess the risk of stroke in patients with atrial fibrillation, guiding the decision for anticoagulation therapy. It evaluates various risk factors including congestive heart failure, hypertension, age, diabetes, prior stroke or transient ischemic attack, vascular disease, and sex category to stratify patients into low, moderate, or high-risk categories.